CHEMGENEX PHARMACEUTICALS LTD - Announcements

Currently unlisted. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CXS	Appendix 3B		28/10/10	119.05KB	Share
CXS	Notice of Annual General Meeting/Proxy Form		22/10/10	126.68KB	Share
CXS	Annual Report to shareholders		22/10/10	1.04MB	Share
CXS	Change of Director's Interest Notice		22/10/10	21.38KB	Share
CXS	Change of Director's Interest Notice		22/10/10	21.49KB	Share
CXS	Becoming a substantial holder		22/10/10	847.24KB	Share
CXS	Convertible Note Issued to Cephalon, Inc	PRICE SENSITIVE	22/10/10	190.64KB	Share
CXS	Appendix 3B		15/10/10	114.06KB	Share
CXS	Response to an ASX Price Query	PRICE SENSITIVE	05/10/10	213.31KB	Share
CXS	ChemGenex Completes pre-NDA Meeting with U.S. FDA	PRICE SENSITIVE	05/10/10	149.61KB	Share
CXS	Presentation at International Investment Conference		13/09/10	1.31MB	Share
CXS	Appendix 3B		06/09/10	113.98KB	Share
CXS	Preliminary Final Report	PRICE SENSITIVE	27/08/10	375.82KB	Share
CXS	Appendix 3B		09/08/10	115.71KB	Share
CXS	Appendix 3B		02/08/10	113.95KB	Share
CXS	FDA agrees on potential regulatory pathway for OMAPRO	PRICE SENSITIVE	14/07/10	1.35MB	Share
CXS	Change of Director's Interest Notice		28/06/10	20.71KB	Share
CXS	Appendix 3B		28/06/10	113.96KB	Share
CXS	Change in substantial holding		17/06/10	79.53KB	Share
CXS	Appendix 3B		15/06/10	179.61KB	Share
CXS	Announces updated OMAPRO safety data at ASCO		07/06/10	115.65KB	Share
CXS	Appendix 3B		12/05/10	66.67KB	Share
CXS	Investor Update		04/05/10	569.11KB	Share
CXS	Complete Response Letter from FDA Received	PRICE SENSITIVE	12/04/10	29.25KB	Share
CXS	Change of Director's Interest Notice		29/03/10	107.81KB	Share
CXS	Appendix 3B		29/03/10	162.74KB	Share
CXS	Appendix 3B		29/03/10	164.39KB	Share
CXS	Change in substantial holding		26/03/10	76.59KB	Share
CXS	Change in substantial holding		25/03/10	81.07KB	Share
CXS	ODAC seeks validated diganostic before approval of OMAPRO	PRICE SENSITIVE	23/03/10	113.69KB	Share
CXS	Appendix 3B		18/03/10	66.91KB	Share
CXS	Change of Director's Interest Notice		16/03/10	107.88KB	Share
CXS	Appendix 3B		16/03/10	66.6KB	Share
CXS	Appendix 3B		15/03/10	67.81KB	Share
CXS	Appendix 3B		15/03/10	68.26KB	Share
CXS	Appendix 3B		04/03/10	175.66KB	Share
CXS	ODAC Meeting Rescheduled to 22 March 2010		02/03/10	99.43KB	Share
CXS	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/10	411.88KB	Share
CXS	Change in substantial holding		22/02/10	82.07KB	Share
CXS	Change of Director's Interest Notice		11/02/10	21.86KB	Share
CXS	CXSO Option Expiry		09/02/10	438.2KB	Share
CXS	ODAC Postponed Due to Extreme Weather in Washington DC	PRICE SENSITIVE	09/02/10	37.54KB	Share
CXS	Appendix 3B		29/01/10	68.05KB	Share
CXS	Appendix 3B		20/01/10	82.43KB	Share
CXS	Appendix 3B		06/01/10	68.44KB	Share
CXS	Change in substantial holding		31/12/09	82.46KB	Share
CXS	Details of Share Registry address		17/12/09	23.2KB	Share
CXS	Appendix 3B		17/12/09	68.38KB	Share
CXS	Omapro ODAC meeting confirmed for 10 February 2010	PRICE SENSITIVE	17/12/09	37.87KB	Share
CXS	Investor Briefing - Teleconference/Webcast		14/12/09	28.29KB	Share
CXS	Omacetaxine European rights licensed to Hospira	PRICE SENSITIVE	14/12/09	42.85KB	Share
CXS	Updated omacetaxine data from multiTKI failure study	PRICE SENSITIVE	09/12/09	46.97KB	Share
CXS	Omapro Data Highlighted at ASH Press Conference	PRICE SENSITIVE	07/12/09	50.61KB	Share
CXS	Change of Director's Interest Notice		03/12/09	20.67KB	Share
CXS	Appendix 3B		01/12/09	68.05KB	Share
CXS	Presentation of Data at Annual ASH Meeting		01/12/09	42.37KB	Share
CXS	Appendix 3B		30/11/09	69.29KB	Share
CXS	Results of Meeting		30/11/09	38.31KB	Share
CXS	Chairman's Address to Shareholders		30/11/09	22.53KB	Share
CXS	CEO's Presentation AGM 2009		30/11/09	618.44KB	Share
CXS	EMEA validates ChemGenex's MAA for omacetaxine	PRICE SENSITIVE	27/11/09	42.05KB	Share
CXS	US FDA accepts Omapro NDA - grants priority review	PRICE SENSITIVE	10/11/09	41.66KB	Share
CXS	Appendix 3B		02/11/09	49.31KB	Share
CXS	Annual Report to shareholders		28/10/09	831.52KB	Share
CXS	Notice of Annual General Meeting/Proxy Form		28/10/09	148.61KB	Share
CXS	CEO Receives AusBiotech Award		28/10/09	49.86KB	Share
CXS	Corporate presentation September 2009		10/09/09	325.93KB	Share
CXS	Presentation at International Investment Conference		09/09/09	33.01KB	Share
CXS	Submits New Drug Application for Omacetaxine to FDA		09/09/09	42.04KB	Share
CXS	Preliminary Final Report	PRICE SENSITIVE	27/08/09	341.27KB	Share
CXS	Details of Share Registry address		19/08/09	37.11KB	Share
CXS	Appendix 3B		10/08/09	49.79KB	Share
CXS	Director Appointment/Resignation		21/07/09	61.16KB	Share
CXS	Appointment of Chief Commercial Officer		20/07/09	40.65KB	Share
CXS	Appendix 3B		07/07/09	49.09KB	Share
CXS	ChemGenex to de-list from NASDAQ and restructure Board		29/06/09	40.86KB	Share
CXS	Appendix 3B		25/06/09	49.17KB	Share
CXS	Response to an ASX Query - Director's Interest Notice		24/06/09	163.83KB	Share
CXS	Change in substantial holding		17/06/09	119.48KB	Share
CXS	Change of Director's Interest Notice		12/06/09	22.14KB	Share
CXS	Change of Director's Interest Notice		12/06/09	22.12KB	Share
CXS	Change of Director's Interest Notice		12/06/09	22.07KB	Share
CXS	Investor Update		11/06/09	255.25KB	Share
CXS	Investor briefing teleconference/webcast		10/06/09	37.24KB	Share
CXS	Omacetaxine Kills Leukemic Stem Cells in Human CML Models	PRICE SENSITIVE	09/06/09	39.58KB	Share
CXS	Omacetaxine Shows Activity in Refractory CML	PRICE SENSITIVE	09/06/09	45.64KB	Share
CXS	Omacetaxine Clinical Data Presented at ASCO	PRICE SENSITIVE	02/06/09	45.34KB	Share
CXS	Change in substantial holding		01/06/09	85.03KB	Share
CXS	Details of Rights Issue Scale-Back		29/05/09	39.56KB	Share
CXS	Rights Issue Fully Subscribed, Further $1 Million Placement	PRICE SENSITIVE	27/05/09	44.53KB	Share
CXS	s708A(5)(e) Disclosure Notice - Share issuance		27/05/09	40.24KB	Share
CXS	Appendix 3B		27/05/09	52.52KB	Share
CXS	Omacetaxine to be Showcased at EHA		21/05/09	38.77KB	Share
CXS	Rights Issue Entitlement Reminder		15/05/09	39.27KB	Share
CXS	Omacetaxine Oral Presentation at ASCO		15/05/09	38.13KB	Share
CXS	Change of Director's Interest Notice		14/05/09	13.78KB	Share
CXS	Investor Roadshow presentation		11/05/09	184.11KB	Share
CXS	Rights Issue Information sent to Shareholders		04/05/09	22.31KB	Share
CXS	Change of Director's Interest Notice		04/05/09	50.08KB	Share
CXS	CFO and Company Secretary Transition		04/05/09	36.97KB	Share

CXSAppendix 3B
28/10/10		119.05KB	Share
CXSNotice of Annual General Meeting/Proxy Form
22/10/10		126.68KB	Share
CXSAnnual Report to shareholders
22/10/10		1.04MB	Share
CXSChange of Director's Interest Notice
22/10/10		21.38KB	Share
CXSChange of Director's Interest Notice
22/10/10		21.49KB	Share
CXSBecoming a substantial holder
22/10/10		847.24KB	Share
CXSConvertible Note Issued to Cephalon, Inc
22/10/10	PRICE SENSITIVE	190.64KB	Share
CXSAppendix 3B
15/10/10		114.06KB	Share
CXSResponse to an ASX Price Query
05/10/10	PRICE SENSITIVE	213.31KB	Share
CXSChemGenex Completes pre-NDA Meeting with U.S. FDA
05/10/10	PRICE SENSITIVE	149.61KB	Share
CXSPresentation at International Investment Conference
13/09/10		1.31MB	Share
CXSAppendix 3B
06/09/10		113.98KB	Share
CXSPreliminary Final Report
27/08/10	PRICE SENSITIVE	375.82KB	Share
CXSAppendix 3B
09/08/10		115.71KB	Share
CXSAppendix 3B
02/08/10		113.95KB	Share
CXSFDA agrees on potential regulatory pathway for OMAPRO
14/07/10	PRICE SENSITIVE	1.35MB	Share
CXSChange of Director's Interest Notice
28/06/10		20.71KB	Share
CXSAppendix 3B
28/06/10		113.96KB	Share
CXSChange in substantial holding
17/06/10		79.53KB	Share
CXSAppendix 3B
15/06/10		179.61KB	Share
CXSAnnounces updated OMAPRO safety data at ASCO
07/06/10		115.65KB	Share
CXSAppendix 3B
12/05/10		66.67KB	Share
CXSInvestor Update
04/05/10		569.11KB	Share
CXSComplete Response Letter from FDA Received
12/04/10	PRICE SENSITIVE	29.25KB	Share
CXSChange of Director's Interest Notice
29/03/10		107.81KB	Share
CXSAppendix 3B
29/03/10		162.74KB	Share
CXSAppendix 3B
29/03/10		164.39KB	Share
CXSChange in substantial holding
26/03/10		76.59KB	Share
CXSChange in substantial holding
25/03/10		81.07KB	Share
CXSODAC seeks validated diganostic before approval of OMAPRO
23/03/10	PRICE SENSITIVE	113.69KB	Share
CXSAppendix 3B
18/03/10		66.91KB	Share
CXSChange of Director's Interest Notice
16/03/10		107.88KB	Share
CXSAppendix 3B
16/03/10		66.6KB	Share
CXSAppendix 3B
15/03/10		67.81KB	Share
CXSAppendix 3B
15/03/10		68.26KB	Share
CXSAppendix 3B
04/03/10		175.66KB	Share
CXSODAC Meeting Rescheduled to 22 March 2010
02/03/10		99.43KB	Share
CXSHalf Yearly Report and Accounts
25/02/10	PRICE SENSITIVE	411.88KB	Share
CXSChange in substantial holding
22/02/10		82.07KB	Share
CXSChange of Director's Interest Notice
11/02/10		21.86KB	Share
CXSCXSO Option Expiry
09/02/10		438.2KB	Share
CXSODAC Postponed Due to Extreme Weather in Washington DC
09/02/10	PRICE SENSITIVE	37.54KB	Share
CXSAppendix 3B
29/01/10		68.05KB	Share
CXSAppendix 3B
20/01/10		82.43KB	Share
CXSAppendix 3B
06/01/10		68.44KB	Share
CXSChange in substantial holding
31/12/09		82.46KB	Share
CXSDetails of Share Registry address
17/12/09		23.2KB	Share
CXSAppendix 3B
17/12/09		68.38KB	Share
CXSOmapro ODAC meeting confirmed for 10 February 2010
17/12/09	PRICE SENSITIVE	37.87KB	Share
CXSInvestor Briefing - Teleconference/Webcast
14/12/09		28.29KB	Share
CXSOmacetaxine European rights licensed to Hospira
14/12/09	PRICE SENSITIVE	42.85KB	Share
CXSUpdated omacetaxine data from multiTKI failure study
09/12/09	PRICE SENSITIVE	46.97KB	Share
CXSOmapro Data Highlighted at ASH Press Conference
07/12/09	PRICE SENSITIVE	50.61KB	Share
CXSChange of Director's Interest Notice
03/12/09		20.67KB	Share
CXSAppendix 3B
01/12/09		68.05KB	Share
CXSPresentation of Data at Annual ASH Meeting
01/12/09		42.37KB	Share
CXSAppendix 3B
30/11/09		69.29KB	Share
CXSResults of Meeting
30/11/09		38.31KB	Share
CXSChairman's Address to Shareholders
30/11/09		22.53KB	Share
CXSCEO's Presentation AGM 2009
30/11/09		618.44KB	Share
CXSEMEA validates ChemGenex's MAA for omacetaxine
27/11/09	PRICE SENSITIVE	42.05KB	Share
CXSUS FDA accepts Omapro NDA - grants priority review
10/11/09	PRICE SENSITIVE	41.66KB	Share
CXSAppendix 3B
02/11/09		49.31KB	Share
CXSAnnual Report to shareholders
28/10/09		831.52KB	Share
CXSNotice of Annual General Meeting/Proxy Form
28/10/09		148.61KB	Share
CXSCEO Receives AusBiotech Award
28/10/09		49.86KB	Share
CXSCorporate presentation September 2009
10/09/09		325.93KB	Share
CXSPresentation at International Investment Conference
09/09/09		33.01KB	Share
CXSSubmits New Drug Application for Omacetaxine to FDA
09/09/09		42.04KB	Share
CXSPreliminary Final Report
27/08/09	PRICE SENSITIVE	341.27KB	Share
CXSDetails of Share Registry address
19/08/09		37.11KB	Share
CXSAppendix 3B
10/08/09		49.79KB	Share
CXSDirector Appointment/Resignation
21/07/09		61.16KB	Share
CXSAppointment of Chief Commercial Officer
20/07/09		40.65KB	Share
CXSAppendix 3B
07/07/09		49.09KB	Share
CXSChemGenex to de-list from NASDAQ and restructure Board
29/06/09		40.86KB	Share
CXSAppendix 3B
25/06/09		49.17KB	Share
CXSResponse to an ASX Query - Director's Interest Notice
24/06/09		163.83KB	Share
CXSChange in substantial holding
17/06/09		119.48KB	Share
CXSChange of Director's Interest Notice
12/06/09		22.14KB	Share
CXSChange of Director's Interest Notice
12/06/09		22.12KB	Share
CXSChange of Director's Interest Notice
12/06/09		22.07KB	Share
CXSInvestor Update
11/06/09		255.25KB	Share
CXSInvestor briefing teleconference/webcast
10/06/09		37.24KB	Share
CXSOmacetaxine Kills Leukemic Stem Cells in Human CML Models
09/06/09	PRICE SENSITIVE	39.58KB	Share
CXSOmacetaxine Shows Activity in Refractory CML
09/06/09	PRICE SENSITIVE	45.64KB	Share
CXSOmacetaxine Clinical Data Presented at ASCO
02/06/09	PRICE SENSITIVE	45.34KB	Share
CXSChange in substantial holding
01/06/09		85.03KB	Share
CXSDetails of Rights Issue Scale-Back
29/05/09		39.56KB	Share
CXSRights Issue Fully Subscribed, Further $1 Million Placement
27/05/09	PRICE SENSITIVE	44.53KB	Share
CXSs708A(5)(e) Disclosure Notice - Share issuance
27/05/09		40.24KB	Share
CXSAppendix 3B
27/05/09		52.52KB	Share
CXSOmacetaxine to be Showcased at EHA
21/05/09		38.77KB	Share
CXSRights Issue Entitlement Reminder
15/05/09		39.27KB	Share
CXSOmacetaxine Oral Presentation at ASCO
15/05/09		38.13KB	Share
CXSChange of Director's Interest Notice
14/05/09		13.78KB	Share
CXSInvestor Roadshow presentation
11/05/09		184.11KB	Share
CXSRights Issue Information sent to Shareholders
04/05/09		22.31KB	Share
CXSChange of Director's Interest Notice
04/05/09		50.08KB	Share
CXSCFO and Company Secretary Transition
04/05/09		36.97KB	Share

REFRESH

First 2

CHEMGENEX PHARMACEUTICALS LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available